BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roma-Rodrigues C, Rivas-García L, Baptista PV, Fernandes AR. Gene Therapy in Cancer Treatment: Why Go Nano? Pharmaceutics 2020;12:E233. [PMID: 32151052 DOI: 10.3390/pharmaceutics12030233] [Cited by in Crossref: 29] [Cited by in F6Publishing: 58] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Xu W, Ye C, Qing X, Liu S, Lv X, Wang W, Dong X, Zhang Y. Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy. Mater Today Bio 2022;16:100358. [PMID: 35880099 DOI: 10.1016/j.mtbio.2022.100358] [Reference Citation Analysis]
2 Madej M, Kurowska N, Strzalka-mrozik B. Polymeric Nanoparticles—Tools in a Drug Delivery System in Selected Cancer Therapies. Applied Sciences 2022;12:9479. [DOI: 10.3390/app12199479] [Reference Citation Analysis]
3 Alwani S, Rai R, Zittlau I, Rekve J, Michel D, Badea I. Design of Smart Nanodiamonds: Introducing pH Sensitivity to Improve Nucleic Acid Carrier Efficiency of Diamoplexes. Pharmaceutics 2022;14:1794. [DOI: 10.3390/pharmaceutics14091794] [Reference Citation Analysis]
4 Cheng D, Theivendran S, Tang J, Cai L, Zhang J, Song H, Yu C. Surface chemistry of spiky silica nanoparticles tailors polyethyleneimine binding and intracellular DNA delivery. J Colloid Interface Sci 2022;628:297-305. [PMID: 35998455 DOI: 10.1016/j.jcis.2022.08.038] [Reference Citation Analysis]
5 Al Bostami RD, Abuwatfa WH, Husseini GA. Recent Advances in Nanoparticle-Based Co-Delivery Systems for Cancer Therapy. Nanomaterials 2022;12:2672. [DOI: 10.3390/nano12152672] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Hejabi F, Abbaszadeh MS, Taji S, O’neill A, Farjadian F, Doroudian M. Nanocarriers: A novel strategy for the delivery of CRISPR/Cas systems. Front Chem 2022;10:957572. [DOI: 10.3389/fchem.2022.957572] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Drozd VS, Eldeeb AA, Kolpashchikov DM, Nedorezova DD. Binary Antisense Oligonucleotide Agent for Cancer Marker-Dependent Degradation of Targeted RNA. Nucleic Acid Therapeutics. [DOI: 10.1089/nat.2021.0108] [Reference Citation Analysis]
8 Toma I, Porfire AS, Tefas LR, Berindan-Neagoe I, Tomuță I. A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA. Pharmaceutics 2022;14:1482. [PMID: 35890377 DOI: 10.3390/pharmaceutics14071482] [Reference Citation Analysis]
9 Bagasariya D, Charankumar K, Shah S, Famta P, Khatri D, Singh Raghuvanshi R, Bala Singh S, Srivastava S. Biomimetic Nanotherapeutics: Employing Nanoghosts to fight Melanoma. Eur J Pharm Biopharm 2022:S0939-6411(22)00137-0. [PMID: 35787429 DOI: 10.1016/j.ejpb.2022.06.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Kang W, Tian Y, Zhao Y, Yin X, Teng Z. Applications of nanocomposites based on zeolitic imidazolate framework-8 in photodynamic and synergistic anti-tumor therapy. RSC Adv 2022;12:16927-41. [PMID: 35754870 DOI: 10.1039/d2ra01102f] [Reference Citation Analysis]
11 Dehshahri A, Khalvati B, Taheri Z, Safari F, Mohammadinejad R, Heydari A. Interleukin-12 Plasmid DNA Delivery by N-[(2-Hydroxy-3-trimethylammonium)propyl]chitosan-Based Nanoparticles. Polymers (Basel) 2022;14:2176. [PMID: 35683849 DOI: 10.3390/polym14112176] [Reference Citation Analysis]
12 Włodarczyk A, Gorgoń S, Radoń A, Bajdak-Rusinek K. Magnetite Nanoparticles in Magnetic Hyperthermia and Cancer Therapies: Challenges and Perspectives. Nanomaterials (Basel) 2022;12:1807. [PMID: 35683663 DOI: 10.3390/nano12111807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ju Y, Liao H, Richardson JJ, Guo J, Caruso F. Nanostructured particles assembled from natural building blocks for advanced therapies. Chem Soc Rev 2022. [PMID: 35471996 DOI: 10.1039/d1cs00343g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Marcovici I, Coricovac D, Pinzaru I, Macasoi IG, Popescu R, Chioibas R, Zupko I, Dehelean CA. Melanin and Melanin-Functionalized Nanoparticles as Promising Tools in Cancer Research-A Review. Cancers (Basel) 2022;14:1838. [PMID: 35406610 DOI: 10.3390/cancers14071838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Elsadek NE, Nagah A, Ibrahim TM, Chopra H, Ghonaim GA, Emam SE, Cavalu S, Attia MS. Electrospun Nanofibers Revisited: An Update on the Emerging Applications in Nanomedicine. Materials (Basel) 2022;15:1934. [PMID: 35269165 DOI: 10.3390/ma15051934] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Zare I, Yaraki MT, Speranza G, Najafabadi AH, Haghighi AS, Nik AB, Manshian BB, Saraiva C, Soenen SJ, Kogan MJ, Lee JW, Apollo NV, Bernardino L, Araya E, Mayer D, Mao G, Hamblin MR. Gold nanostructures: synthesis, properties, and neurological applications. Chem Soc Rev 2022. [PMID: 35234776 DOI: 10.1039/d1cs01111a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
17 Gellings P, Galeas-pena M, Morici LA. Mycobacterium bovis bacille Calmette–Guerin-derived extracellular vesicles as an alternative to live BCG immunotherapy. Clin Exp Med. [DOI: 10.1007/s10238-022-00794-4] [Reference Citation Analysis]
18 Saurav S, Manna SK. Increased expression of Profilin potentiates chemotherapeutic agent-mediated tumour regression. Br J Cancer. [DOI: 10.1038/s41416-021-01683-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Jerzykiewicz J, Czogalla A. Polyethyleneimine-Based Lipopolyplexes as Carriers in Anticancer Gene Therapies. Materials (Basel) 2021;15:179. [PMID: 35009324 DOI: 10.3390/ma15010179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Guo K, Xiao N, Liu Y, Wang Z, Tóth J, Gyenis J, Thakur VK, Oyane A, Shubhra QT. Engineering polymer nanoparticles using cell membrane coating technology and their application in cancer treatments: Opportunities and challenges. Nano Materials Science 2021. [DOI: 10.1016/j.nanoms.2021.12.001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Asfiya R, Maiti B, Kamra M, Karande AA, Bhattacharya S. Novel α-tocopherol-ferrocene conjugates for the specific delivery of transgenes in liver cancer cells under high serum conditions. Biomater Sci 2021;9:7636-47. [PMID: 34676384 DOI: 10.1039/d1bm00607j] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Wu X, Yokoyama Y, Takahashi H, Kouda S, Yamamoto H, Wang J, Morimoto Y, Minami K, Hata T, Shamma A, Inoue A, Ohtsuka M, Shibata S, Kobayashi S, Akai S, Yamamoto H. Improved In Vivo Delivery of Small RNA Based on the Calcium Phosphate Method. J Pers Med 2021;11:1160. [PMID: 34834512 DOI: 10.3390/jpm11111160] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Er S, Laraib U, Arshad R, Sargazi S, Rahdar A, Pandey S, Thakur VK, Díez-Pascual AM. Amino Acids, Peptides, and Proteins: Implications for Nanotechnological Applications in Biosensing and Drug/Gene Delivery. Nanomaterials (Basel) 2021;11:3002. [PMID: 34835766 DOI: 10.3390/nano11113002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sharifi-Rad J, Quispe C, Patra JK, Singh YD, Panda MK, Das G, Adetunji CO, Michael OS, Sytar O, Polito L, Živković J, Cruz-Martins N, Klimek-Szczykutowicz M, Ekiert H, Choudhary MI, Ayatollahi SA, Tynybekov B, Kobarfard F, Muntean AC, Grozea I, Daştan SD, Butnariu M, Szopa A, Calina D. Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy. Oxid Med Cell Longev 2021;2021:3687700. [PMID: 34707776 DOI: 10.1155/2021/3687700] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
25 Gutiérrez-Romero L, Rivas-García L, Sánchez-González C, Llopis J, Blanco E, Montes-Bayón M. Cellular Toxicity Mechanisms and the Role of Autophagy in Pt(IV) Prodrug-Loaded Ultrasmall Iron Oxide Nanoparticles Used for Enhanced Drug Delivery. Pharmaceutics 2021;13:1730. [PMID: 34684023 DOI: 10.3390/pharmaceutics13101730] [Reference Citation Analysis]
26 Pengnam S, Plianwong S, Yingyongnarongkul BE, Patrojanasophon P, Opanasopit P. Delivery of small interfering RNAs by nanovesicles for cancer therapy. Drug Metab Pharmacokinet 2021;42:100425. [PMID: 34954489 DOI: 10.1016/j.dmpk.2021.100425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
27 Nehra M, Uthappa UT, Kumar V, Kumar R, Dixit C, Dilbaghi N, Mishra YK, Kumar S, Kaushik A. Nanobiotechnology-assisted therapies to manage brain cancer in personalized manner. J Control Release 2021;338:224-43. [PMID: 34418523 DOI: 10.1016/j.jconrel.2021.08.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
28 Tong T, Guan Y, Gao Y, Xing C, Zhang S, Jiang D, Yang X, Kang Y, Pang J. Smart nanocarriers as therapeutic platforms for bladder cancer. Nano Res 2022;15:2157-76. [DOI: 10.1007/s12274-021-3753-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Fu Z, Wang L, Li S, Chen F, Au-Yeung KK, Shi C. MicroRNA as an Important Target for Anticancer Drug Development. Front Pharmacol 2021;12:736323. [PMID: 34512363 DOI: 10.3389/fphar.2021.736323] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
30 Luo D, Xu X, Iqbal MZ, Zhao Q, Zhao R, Farheen J, Zhang Q, Zhang P, Kong X. siRNA-Loaded Hydroxyapatite Nanoparticles for KRAS Gene Silencing in Anti-Pancreatic Cancer Therapy. Pharmaceutics 2021;13:1428. [PMID: 34575504 DOI: 10.3390/pharmaceutics13091428] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Mehta M, Paudel KR, Shukla SD, Allam VSRR, Kannaujiya VK, Panth N, Das A, Parihar VK, Chakraborty A, Ali MK, Jha NK, Xenaki D, Su QP, Wich PR, Adams J, Hansbro PM, Chellappan DK, Oliver BGG, Dua K. Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases. J Control Release 2021;337:629-44. [PMID: 34375688 DOI: 10.1016/j.jconrel.2021.08.010] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
32 Hayat H, Nukala A, Nyamira A, Fan J, Wang P. A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine. Biomed Mater 2021;16. [PMID: 34280907 DOI: 10.1088/1748-605X/ac15b2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Yu Y, Feng Z, Liu J, Hou X, Zhou X, Gao J, Wang W, Zhang Y, Li G, Liu J. γ-Ray-Triggered Drug Release of Reactive Oxygen Species-Sensitive Nanomedicine for Enhanced Concurrent Chemoradiation Therapy. ACS Omega 2021;6:19445-57. [PMID: 34368532 DOI: 10.1021/acsomega.1c01500] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Yang HZ, Zhang J, Guo Y, Pu L, Yu XQ. A Fluorescent Self-Reporting Vector with GSH Reduction Responsiveness for Nucleic Acid Delivery. ACS Appl Bio Mater 2021;4:5717-26. [PMID: 35006755 DOI: 10.1021/acsabm.1c00484] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Pylaev T, Avdeeva E, Khlebtsov N. Plasmonic nanoparticles and nucleic acids hybrids for targeted gene delivery, bioimaging, and molecular recognition. J Innov Opt Health Sci 2021;14:2130003. [DOI: 10.1142/s1793545821300032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Attia N, Mashal M, Puras G, Pedraz JL. Mesenchymal Stem Cells as a Gene Delivery Tool: Promise, Problems, and Prospects. Pharmaceutics 2021;13:843. [PMID: 34200425 DOI: 10.3390/pharmaceutics13060843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Medici S, Peana M, Coradduzza D, Zoroddu MA. Gold nanoparticles and cancer: Detection, diagnosis and therapy. Seminars in Cancer Biology 2021. [DOI: 10.1016/j.semcancer.2021.06.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
38 Cole L, Fernandes D, Hussain MT, Kaszuba M, Stenson J, Markova N. Characterization of Recombinant Adeno-Associated Viruses (rAAVs) for Gene Therapy Using Orthogonal Techniques. Pharmaceutics 2021;13:586. [PMID: 33923984 DOI: 10.3390/pharmaceutics13040586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
39 Pengnam S, Plianwong S, Patrojanasophon P, Radchatawedchakoon W, Yingyongnarongkul BE, Opanasopit P, Charoensuksai P. Synergistic Effect of Doxorubicin and siRNA-Mediated Silencing of Mcl-1 Using Cationic Niosomes against 3D MCF-7 Spheroids. Pharmaceutics 2021;13:550. [PMID: 33919902 DOI: 10.3390/pharmaceutics13040550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
40 Chaudhary S, Singh A, Kumar P, Kaushik M. Strategic targeting of non-small-cell lung cancer utilizing genetic material-based delivery platforms of nanotechnology. J Biochem Mol Toxicol 2021;35:e22784. [PMID: 33826765 DOI: 10.1002/jbt.22784] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
41 Mdlovu NV, Lin K, Chen Y, Wu C. Formulation of magnetic nanocomposites for intracellular delivery of micro-RNA for MYCN inhibition in neuroblastoma. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2021;615:126264. [DOI: 10.1016/j.colsurfa.2021.126264] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
42 Faneca H. Non-Viral Gene Delivery Systems. Pharmaceutics 2021;13:446. [PMID: 33810390 DOI: 10.3390/pharmaceutics13040446] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
43 Briolay T, Petithomme T, Fouet M, Nguyen-Pham N, Blanquart C, Boisgerault N. Delivery of cancer therapies by synthetic and bio-inspired nanovectors. Mol Cancer 2021;20:55. [PMID: 33761944 DOI: 10.1186/s12943-021-01346-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
44 Costa D, Santo D, Domingues C, Veiga F, Faneca H, Figueiras A. Recent advances in peptide-targeted micelleplexes: Current developments and future perspectives. Int J Pharm 2021;597:120362. [PMID: 33556489 DOI: 10.1016/j.ijpharm.2021.120362] [Reference Citation Analysis]
45 Reche-Perez FJ, Plesselova S, De Los Reyes-Berbel E, Ortega-Muñoz M, Lopez-Jaramillo FJ, Hernandez-Mateo F, Santoyo-Gonzalez F, Salto-Gonzalez R, Giron-Gonzalez MD. Single chain variable fragment fused to maltose binding protein: a modular nanocarrier platform for the targeted delivery of antitumorals. Biomater Sci 2021;9:1728-38. [PMID: 33432316 DOI: 10.1039/d0bm01903h] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
46 Wang M, Ibeagha-Awemu EM. Impacts of Epigenetic Processes on the Health and Productivity of Livestock. Front Genet 2020;11:613636. [PMID: 33708235 DOI: 10.3389/fgene.2020.613636] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
47 Gagliardi A, Giuliano E, Venkateswararao E, Fresta M, Bulotta S, Awasthi V, Cosco D. Biodegradable Polymeric Nanoparticles for Drug Delivery to Solid Tumors. Front Pharmacol 2021;12:601626. [PMID: 33613290 DOI: 10.3389/fphar.2021.601626] [Cited by in Crossref: 17] [Cited by in F6Publishing: 71] [Article Influence: 17.0] [Reference Citation Analysis]
48 Rivas-García L, Quiles JL, Varela-López A, Giampieri F, Battino M, Bettmer J, Montes-Bayón M, Llopis J, Sánchez-González C. Ultra-Small Iron Nanoparticles Target Mitochondria Inducing Autophagy, Acting on Mitochondrial DNA and Reducing Respiration. Pharmaceutics 2021;13:90. [PMID: 33445442 DOI: 10.3390/pharmaceutics13010090] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
49 Anani T, Rahmati S, Sultana N, David AE. MRI-traceable theranostic nanoparticles for targeted cancer treatment. Theranostics 2021;11:579-601. [PMID: 33391494 DOI: 10.7150/thno.48811] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 17.0] [Reference Citation Analysis]
50 Montaño-Samaniego M, Bravo-Estupiñan DM, Méndez-Guerrero O, Alarcón-Hernández E, Ibáñez-Hernández M. Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters. Front Oncol 2020;10:605380. [PMID: 33381459 DOI: 10.3389/fonc.2020.605380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
51 Huo W, Li X, Wang B, Zhang H, Zhang J, Yang X, Jin Y. Recent advances of DNAzyme-based nanotherapeutic platform in cancer gene therapy. Biophys Rep 2020;6:256-65. [DOI: 10.1007/s41048-020-00123-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
52 Zukancic D, Suys EJA, Pilkington EH, Algarni A, Al-Wassiti H, Truong NP. The Importance of Poly(ethylene glycol) and Lipid Structure in Targeted Gene Delivery to Lymph Nodes by Lipid Nanoparticles. Pharmaceutics 2020;12:E1068. [PMID: 33182382 DOI: 10.3390/pharmaceutics12111068] [Cited by in Crossref: 18] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
53 Nabavinia M, Beltran-huarac J. Recent Progress in Iron Oxide Nanoparticles as Therapeutic Magnetic Agents for Cancer Treatment and Tissue Engineering. ACS Appl Bio Mater 2020;3:8172-87. [DOI: 10.1021/acsabm.0c00947] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
54 Roma-Rodrigues C, Pombo I, Fernandes AR, Baptista PV. Hyperthermia Induced by Gold Nanoparticles and Visible Light Photothermy Combined with Chemotherapy to Tackle Doxorubicin Sensitive and Resistant Colorectal Tumor 3D Spheroids. Int J Mol Sci 2020;21:E8017. [PMID: 33126535 DOI: 10.3390/ijms21218017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
55 Fischer D, Dusek N, Hotzel K, Heinze T. The Role of Formamidine Groups in Dextran Based Nonviral Vectors for Gene Delivery on Their Physicochemical and Biological Characteristics. Macromol Biosci 2021;21:e2000220. [PMID: 33025658 DOI: 10.1002/mabi.202000220] [Reference Citation Analysis]
56 Vicente‐ruiz S, Serrano‐martí A, Armiñán A, Vicent MJ. Nanomedicine for the Treatment of Advanced Prostate Cancer. Adv Therap 2021;4:2000136. [DOI: 10.1002/adtp.202000136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Ferreira D, Fontinha D, Martins C, Pires D, Fernandes AR, Baptista PV. Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics. Molecules 2020;25:E3489. [PMID: 32751935 DOI: 10.3390/molecules25153489] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
58 Song J, Ma P, Huang S, Wang J, Xie H, Jia B, Zhang W. Acylation of the antimicrobial peptide CAMEL for cancer gene therapy. Drug Deliv 2020;27:964-73. [PMID: 32611259 DOI: 10.1080/10717544.2020.1787556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]